| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Health Care (XLV) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Health Care sector is very positive (overall 2.6, positive 3.3, negative -0.7) on 20251029. The forces of Sentiment towards Fundamentals (2.2), Price Level (2), Option Speculation (1.5), Broad Market Trend (0.8), and Sector Price Trend (-0.4) will drive up the price. The forces of Valuation Sentiment (-1), and Market Risk Prefrence (0) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (3.3). The extreme bullish overall sentiment (2.6) may signal the top of this uptrend. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XLV trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-29 | 1% | 1% | 144.05 | 47 | -0.95% | 0.07% | 1.7 | -0.4 | 2.1 | -0.9 |
| 2025-10-28 | 2% | 1% | 145.44 | 74 | -0.65% | 0.21% | 1.8 | 0.2 | 2 | 5.2 |
| 2025-10-27 | 1% | 1% | 146.38 | 87 | 0.23% | 0.35% | 1.5 | 0.3 | 1.9 | 2.9 |
| 2025-10-26 | 1% | 1% | 1.3 | 0.4 | 2 | 1 | ||||
| 2025-10-25 | 0% | 0.9% | 1.3 | 0.4 | 2 | 0 | ||||
| 2025-10-24 | 1% | 0.9% | 146.05 | 79 | 0.01% | 0.28% | 1.4 | 0.4 | 2.2 | 0.9 |
| 2025-10-23 | 1% | 1% | 146.04 | 79 | 0.02% | 0.07% | 1.5 | 0.7 | 2.3 | 3.7 |
| 2025-10-22 | 1% | 1% | 146 | 79 | 0.65% | 0.14% | 1.3 | 0.7 | 2.3 | 1.2 |
| 2025-10-21 | 2% | 1.1% | 145.06 | 75 | 0.21% | 0.07% | 1.5 | 0.6 | 2.4 | 4.4 |
| 2025-10-20 | 1% | 1.1% | 144.76 | 75 | 1.06% | 0% | 1.3 | 0.5 | 2.5 | 6.3 |
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (0) Marjorie Taylor Greene Buys 6 Stocks: Buffett, Health Care — And This Magnificent 7 Stock Marjorie Taylor Greene discloses buying more stocks in October. Here's a look at what she added to her portfolio. (https://www.benzinga.com/) Wed. Oct 29, 2025 | |
| 2 (8) Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery. (https://www.cnbc.com/) Wed. Oct 29, 2025 | |
| 3 (8) CVS earnings 'absolutely delivered' with outlook, record sales CVS Health (CVS) stock is in focus after the company reported record-high revenue and lifted its full-year outlook. Grey Ghost Capital healthcare investor and Tenet Healthcare (THC) board member, Meghan Fitzgerald, joins Market Catalysts to discuss the earnings print and CVS's ongoing turnaround efforts. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts. (https://finance.yahoo.com/) Wed. Oct 29, 2025 | |
| 4 (-7) This Open Enrollment Might Give You Sticker Shock Americans embarking on the annual task of sifting through the health plans offered by their employers to find the one that gives them the most bang for their buck are facing a new reality: many of those options no longer feel affordable. This year, the process isn’t just complex or confusing — it’s painful. (https://www.bloomberg.com/) Wed. Oct 29, 2025 | |
| 5 (-8) Hit By Costs And Medicaid Cuts, Centene Reports $6.6 Billion Loss Centene reported a $6.6 billion third-quarter loss as the health insurer struggles to control healthcare costs in the government-subsidized health plans it administers. (https://www.forbes.com/) Wed. Oct 29, 2025 | |
| 6 (3) Harry You SPAC Plans to Merge With Clinic-in-a-Box Firm OnMed Blank-check deal veteran Harry You’s latest special purpose acquisition company is looking to merge with a business that operates portable health-care stations. (https://www.bloomberg.com/) Wed. Oct 29, 2025 | |
| 7 (-4) Old Drugs Usually Go Way Down in Price. Here’s Why This One Skyrocketed The MS medication Rebif is one of a group of complex speciality drugs that are hard to copy. (https://www.bloomberg.com/) Wed. Oct 29, 2025 | |
| 8 (-4) Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried? It's not the end of the world for the drugmaker. (https://www.fool.com/) Wed. Oct 29, 2025 | |
| 9 (-6) CVS books a $5.7 billion loss in its health-services business, tarnishing upbeat earnings CVS Health’s stock falls as a large charge to write off the value of an underperforming business takes the shine off an otherwise strong earnings report. (https://www.marketwatch.com/) Wed. Oct 29, 2025 | |
| 10 (-7) CVS books a $5.7 billion loss in its health-services business, tarnishing upbeat earnings CVS Health’s stock falls as a large charge to write off the value of an underperforming business takes the shine off an otherwise strong earnings report. (https://www.marketwatch.com/) Wed. Oct 29, 2025 | |
| 11 (7) GSK seen posting steady Q3 on shingles vaccine strength, FX tailwind GSK seen posting steady Q3 on shingles vaccine strength, FX tailwind (https://www.investing.com/) Wed. Oct 29, 2025 | |
| 12 (7) UnitedHealth Earnings Top Expectations, as Insurer Works Toward a Turnaround The health care giant topped earnings estimates and raised its 2025 guidance after a series of setbacks. (https://www.investopedia.com/) Tue. Oct 28, 2025 | |
| 13 (5) Sticking With This Labcorp Price Target as Shares Take a Hit Timing issues are weighing on the shares, but we continue to like the long-term narrative. (https://www.thestreet.com/) Tue. Oct 28, 2025 | |
| 14 (6) US Obesity Rate Sees Decline As Weight Loss Drugs Gain Ground According to the Gallup National Health and Well-Being Index, the share of adults in the U.S. who are obese dropped slightly from 39.9 percent in 2022 to 37 percent in 2025, signifying a small but meaningful decline after years of little change. (https://www.rttnews.com/) Tue. Oct 28, 2025 | |
| 15 (8) Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support Labcorp posts Q3 EPS of $4.18 and sales of $3.56 billion, exceeding estimates, while revising 2025 guidance amid strong diagnostics and lab growth. (https://www.benzinga.com/) Tue. Oct 28, 2025 | |
| 16 (8) Lilly partners with Nvidia on AI supercomputer to speed up drug development Using the supercomputer, scientists at Lilly will be able to train AI models on millions of experiments to test potential medicines, expanding the scope of drug discovery efforts, the company said. A number of these proprietary AI models will be available on Lilly TuneLab, a federated artificial-intelligence and machine-learning platform that allows biotech companies access to drug discovery models trained on years of its research data. The federated model is a privacy-preserving approach that enables biotechs to tap into Lilly's AI models without directly exposing either their or Lilly's proprietary data. (https://finance.yahoo.com/) Tue. Oct 28, 2025 | |
| 17 (-6) Philips Gets Warning Letter From US FDA on Device Facilities Royal Philips NV received a letter from the US Food and Drug Administration warning that three manufacturing sites don’t meet standards, a blow to efforts to draw a line under high-profile issues with some of its products. (https://www.bloomberg.com/) Tue. Oct 28, 2025 | |
| 18 (0) Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings Eli Lilly, Merck, Gilead, Bristol Myers Squibb and AbbVie, among other pharmaceutical companies, are slated to report third-quarter earnings this week. (https://www.cnbc.com/) Tue. Oct 28, 2025 | |
| 19 (7) UnitedHealth Delivers The Quarter Tepper, Burry Have Been Waiting For UnitedHealth Group Inc (UNH) reported strong earnings, giving David Tepper and Michael Burry led hedge funds hope for the future. (https://www.benzinga.com/) Tue. Oct 28, 2025 | |
| 20 (8) UnitedHealth Revenue Rises as Turnaround Efforts Continue The healthcare giant reported revenue rose more than 10%, and its CEO said he was confident of solid earnings growth next year. (https://finance.yahoo.com/) Tue. Oct 28, 2025 | |
| 21 (6) UnitedHealth tops 3Q forecasts as it resets coverage prices to deal with rising costs UnitedHealth has returned to better-than-expected growth after starting the year swamped by medical costs and then withdrawing its forecast for 2025. In the meantime, UnitedHealth is going through a transition year, resetting health insurance prices and trimming unprofitable parts of that business. With 8.4 million customers, UnitedHealth is the nation’s largest provider of Medicare Advantage plans. (https://finance.yahoo.com/) Tue. Oct 28, 2025 | |
| 22 (8) Lilly Makes Billions of Weight-Loss Pills Before US Approval Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global demand ahead of a potential launch next year. (https://www.bloomberg.com/) Tue. Oct 28, 2025 | |
| 23 (8) UnitedHealth lifts 2025 profit forecast, aims for growth in 2026 UnitedHealth raised its annual profit forecast and said it aims to grow in 2026, in a sign that the turnaround efforts were gaining steam. (https://www.cnbc.com/) Tue. Oct 28, 2025 | |
| 24 (5) Novartis CEO says pharma giant has the firepower for big M&A deals: 'Can never be done' Novartis "can never be done" when it comes to major acquisitions in its sector, CEO Vas Narasimhan told CNBC. (https://www.cnbc.com/) Tue. Oct 28, 2025 | |
| 25 (8) UnitedHealth Lifts Outlook As CEO Promises 'Durable Growth' Ahead UnitedHealth stock rises after Q3 earnings beat expectations and the company lifts its 2025 guidance, signaling confidence in future growth. (https://www.benzinga.com/) Tue. Oct 28, 2025 | |
| 26 (0) Trump in Japan; UnitedHealth raises outlook; gold drops - what’s moving markets Trump in Japan; UnitedHealth raises outlook; gold drops - what’s moving markets (https://www.investing.com/) Tue. Oct 28, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA